Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A2YNT30
Wed, 31.08.2022
Alzchem Group AG
DGAP-Media / 31.08.2022 / 14:23 CET/CEST
Joint Press Release Alzchem and Crearene
Alzchem Group AG and Crearene AG, based in Frauenfeld in Switzerland, have agreed on an exclusive memo of understanding (MOU) for the development and commercialization of Creapure®/creatine-based treatment solutions in dialysis.
Dialysis is a treatment method w [ … ]
Tue, 26.07.2022
Alzchem Group AG
Sales growth to EUR 269.8 million mainly due to price effects
EBITDA of EUR 34.9 million almost at previous year’s level
Result for the period slightly higher at EUR 17.4 million
Equity ratio up from 23.7% to 30.9%
Increased sales forecast for fiscal year 2022 confirmed
Trostberg, 26 July 2022 – Alzchem Group AG, a vertically integrated specia [ … ]
Tue, 26.07.2022
Alzchem Group AG
Sales growth to EUR 269.8 million mainly due to price effects
EBITDA of EUR 34.9 million almost at previous year’s level
Result for the period slightly higher at EUR 17.4 million
Equity ratio up from 23.7% to 30.9%
Increased sales forecast for fiscal year 2022 confirmed
Trostberg, 26 July 2022 – Alzchem Group AG, a vertically integrated specia [ … ]
Thu, 05.05.2022
Alzchem Group AG
Annual General Meeting 2022 of Alzchem Group AG: Broad shareholder approval for growth course and dividend increaseTrostberg, 5 May 2022 – Today’s virtual Annual General Meeting of Alzchem Group AG expressed its continued confidence in the Management Board and the Supervisory Board by discharging them for the fiscal year 2021 and approved all agend [ … ]
Mon, 02.05.2022
Alzchem Group AG
Early contract extension with CSO Dr. Georg Weichselbaumer and COO Klaus Englmaier
Trostberg, 2 May 2022 - The Supervisory Board of Alzchem Group AG has extended the Management Board contracts of Dr. Georg Weichselbaumer (CSO) and Klaus Englmaier (COO) ahead of schedule until the end of 2025. Markus Zöllner, Chairman of the Supervisory Board: "Wit [ … ]
Thu, 28.04.2022
Alzchem Group AG
Alzchem Group AG achieves record sales of EUR 129.4 million (+24%) in the first quarter of 2022
EBITDA slightly above previous year at EUR 17.1 million
Equity ratio improved from 23.7% to 28.2%
Sales forecast for the fiscal year 2022 increased
Trostberg, 28 April 2022 - Alzchem Group AG, a vertically integrated specialty chemicals supplier with [ … ]
Thu, 21.04.2022
Alzchem Group AG
Alzchem Group AG receives award from EcoVadis for its sustainability successesTrostberg, 21 April 2022 - Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, has again successfully passed an independent CSR rating by EcoVadis, the world's largest provider of sustainability [ … ]
Wed, 06.04.2022
Alzchem Group AG
DGAP-Media / 06.04.2022 / 15:57
The "International Conference on Creatine in Health and Disease 2022," held March 16-19 and hosted by Alzchem Group AG and others, provided the ideal forum for the world's leading experts to exchange ideas on the state of creatine research.
In addition to leading scientists in the field, the online event brou [ … ]
Thu, 24.02.2022
Alzchem Group AG
Alzchem Group AG: new record levels for sales, EBITDA and annual result in the fiscal year 2021
Sales increase to EUR 422.3 million (+11.3%)
EBITDA grows to EUR 62.0 million (+15.2%)
Annual result climbs to EUR 27.8 million (+39.7%)
Dividend increase from EUR 0.77 per share to EUR 1.00 per share planned
Trostberg, 24 February 2022 - Alzchem Gro [ … ]
Wed, 01.12.2021
Alzchem Group AG
Alzchem positions itself in e-mobility in the fuel cell sector as a technology provider in the production of hydrogen tanks
Fuel cell propulsion solution for road transport, shipping and rail
Contribution to enabling CO₂-neutral trucking as quickly as possible
Trostberg, December 1, 2021 - Alzchem Group AG, a vertically integrated specialty che [ … ]